Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiotensin-(1-7). One step forward?

W Buczko1, I Kucharewicz

  • 1Department of Pharmacodynamics, Medical Academy in Białystok, Poland.

Polish Journal of Pharmacology
|August 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of xanthine oxidoreductase in the anti-thrombotic effects of nitrite in rats in vivo.

Platelets·2015
Same author

Angiotensin-(1-9) enhances stasis-induced venous thrombosis in the rat because of the impairment of fibrinolysis.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2013
Same author

Periodontal pharmacotherapy - an updated review.

Advances in medical sciences·2011
Same author

Angiotensin-(1-9), the product of angiotensin I conversion in platelets, enhances arterial thrombosis in rats.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2010
Same author

Tissue plasminogen activator in the amygdala: a new role for an old protease.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2009
Same author

Nicotinamide and its metabolite N-methylnicotinamide increase skin vascular permeability in rats.

Clinical and experimental dermatology·2009

Angiotensin-(1-7) is a hormone that balances angiotensin II's effects and regulates blood pressure. Its concentration increases with RAS blockers, suggesting a role in their beneficial actions.

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Pharmacology

Background:

  • Angiotensin-(1-7) [Ang-(1-7)] functions as a key paracrine hormone within the renin-angiotensin system (RAS).
  • It counteracts detrimental effects of angiotensin II (Ang II) in cardiovascular, renal, and central nervous systems.
  • Ang-(1-7) plays a crucial role in blood pressure regulation and exhibits antiproliferative properties.

Purpose of the Study:

  • To investigate the role of Ang-(1-7) in the context of RAS modulation.
  • To explore the potential involvement of Ang-(1-7) in the therapeutic effects of RAS blockers.

Main Methods:

  • Review of existing literature on Ang-(1-7) and RAS.
  • Analysis of data showing Ang-(1-7) concentration changes during RAS blocker administration.

Related Experiment Videos

Main Results:

  • Evidence suggests a specific receptor for Ang-(1-7) exists.
  • Significant increases in Ang-(1-7) concentrations were observed during RAS blocker treatment.

Conclusions:

  • The findings support the involvement of Ang-(1-7) in the beneficial outcomes associated with RAS blockers.
  • Further research into the Ang-(1-7) pathway may reveal new therapeutic strategies.